Seroprevalence and associated factors of hepatitis A IgG antibody among HIV-positive people in Tehran, Iran

Seroprevalence and associated factors of hepatitis A IgG antibody among HIV-positive people in Tehran, Iran

Bibliographic Details
Main Authors:	Fatemeh Golsoorat Pahlaviani, SeyedAhmad SeyedAlinaghi, Alireza Abdollahi, Mehrnaz Rasoulinejad, Seyed Dehghan Manshadi, Omid Dadras
Format:	Article
Language:	English
Published:	Termedia Publishing House 2023-09-01
Series:	HIV & AIDS Review. International Journal of HIV-Related Problems
Subjects:	hiv hepatitis a hav antibody seroprevalence
Online Access:	https://www.termedia.pl/Seroprevalence-and-associated-factors-of-hepatitis-A-IgG-antibody-among-HIV-positive-people-in-Tehran-Iran,106,51500,1,1.html

Similar Items

Seroprevalence of Hepatitis A Virus in Inonu University Medical Faculty Hospital, 2015
by: Yucel Duman, et al.
Published: (2017-06-01)

Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines
by: Josefina C. Carlos, et al.
Published: (2024-04-01)

Coping strategies and their correlation with depression, anxiety, and stress among HIV-positive patients referred to voluntary counseling and testing center, Tehran, Iran, 2019
by: Raheleh Golrokhi, et al.
Published: (2023-09-01)

Hepatitis A, B, and C in Brazilian Afro-Descendant Communities from Northeast Brazil: A Seroepidemiological Survey
by: Barbara V. Lago, et al.
Published: (2024-10-01)

Epidemiology and transmission of hepatitis A in Shaanxi (western China) after more than ten years of universal vaccination
by: Xiaotong Hu, et al.
Published: (2023-11-01)

Seroprevalence of antibodies IgG/IgM anti-T. gondii in women of Coro, Venezuela
by: Yotsabeth Saúl-Garcia, et al.
Published: (2019-06-01)

HIV self-testing in Iran: first implementation and feasibility study
by: Seyed Dehghan Manshadi, et al.
Published: (2023-01-01)

Seroprevalence of IgG antibodies against diphtheria antitoxin among migrant workers in Singapore, 2016-2019
by: Ang, Li Wei, et al.
Published: (2022)

Seroprevalence of Hepatitis E Virus Antibodies (IgG) in the Community of Rawalpindi
by: Muhammad Awais Farooqi, et al.
Published: (2022-07-01)

Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis
by: Kathleen Mahan, et al.
Published: (2024-03-01)

Post-exposure HIV prophylaxis adherence to full 28-day course versus weekly therapy in Tehran
by: Ladan Abbasian, et al.
Published: (2024-05-01)

Prevalence of sexually transmitted infections and associated factors among male prisoners in Great Tehran Prison by active case finding
by: Behnam Farhoudi, et al.
Published: (2024-11-01)

Seroprevalence and Risk Factors of Brucellosis in Abattoir Workers in Fars Province, Iran
by: Alireza Zakeri, et al.
Published: (2024-03-01)

Determination of anti-COVID-19 IgG and IgM seroprevalence among pregnant women at Pietersburg Hospital, Limpopo Province, South Africa
by: I Rukasha, et al.
Published: (2024-03-01)

Comparison of Rubella, Cytomegalovirus, Toxoplasma gondii seroprevalence, Still Birth and Preterm Birth Rates in Pregnant Patients Admitted to Our Hospital, IgG Avidity in IgG Positive Patients
by: Esra Gürbüz, et al.
Published: (2021-04-01)

Seroprevalence of antibodies IgG/IgM anti-T. gondii in women of Coro, Venezuela
by: Saúl-García Yotsabeth, et al.
Published: (2019-06-01)

Violence among women living with HIV in Iran: prevalence and related risk factors
by: Hossein Yahyazadeh Pirsaraee, et al.
Published: (2023-12-01)

Seroprevalence of Hepatitis A virus infections among schoolchildren in Amran Governorate, Yemen
by: Ali Ahmed Al-Hadheq, et al.
Published: (2025-02-01)

Seroprevalence of Toxoplasma gondii IgG and IgM antibodies and associated risk factors among pregnant women consulted in three health centers in Dschang, Cameroon
by: Noumedem Anangmo Christelle Nadia, et al.
Published: (2023-08-01)

Seroprevalence of Anti HSV-2 IgG among Women of Reproductive Age attending General Hospital Dutse
by: Sani, N. M.,, et al.
Published: (2019-06-01)

Seroprevalence Survey of Rubella IgG Antibodies among Pregnant Women Attending Antenatal Clinics in Abakaliki, Ebonyi State, Nigeria
by: Ekuma, Uchechukwu Onyeukwu, et al.
Published: (2018-12-01)

Seroprevalence of SARS-CoV-2 IgG in blood donors in a teaching institute from Western part of Maharashtra
by: Rajashri A. Patil, et al.
Published: (2024-05-01)

Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors
by: Aníbal Gaviria, et al.
Published: (2024-06-01)

Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children’s Hospital
by: Marjan Tariverdi, et al.
Published: (2024-02-01)

Prevalence of Hypothyroidism Among Patients With COVID-19 in Tehran City, Iran
by: Fatemeh Esfahanian, et al.
Published: (2023-05-01)

Prolonged Gut Dysbiosis and Fecal Excretion of Hepatitis A Virus in Patients Infected with Human Immunodeficiency Virus
by: Aya Ishizaka, et al.
Published: (2021-10-01)

Cell Culture Systems and Drug Targets for Hepatitis A Virus Infection
by: Tatsuo Kanda, et al.
Published: (2020-05-01)

Seroprevalence of SARS-CoV-2 IgG antibodies among rural children aged 6-14 years in a selected block of West Bengal, India
by: Vineeta Shukla, et al.
Published: (2024-07-01)

Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Healthcare Personnel in El Salvador Prior to Vaccination Campaigns
by: José Elías Aguilar Ramírez, et al.
Published: (2024-06-01)

Seroprevalence and molecular investigation of toxocariasis in working children and control group in Tehran, Iran
by: Farah Bokharaei-Salim, et al.
Published: (2024-05-01)

Seroprevalence of <i>Aspergillus</i>-Specific IgG Antibody among Mozambican Tuberculosis Patients
by: Helmut J. F. Salzer, et al.
Published: (2021-07-01)

ChatGPT in Healthcare Writing: Advantages and Limitations
by: SeyedAhmad SeyedAlinaghi, et al.
Published: (2024-10-01)

Ethical Considerations for AI Use in Healthcare Research
by: SeyedAhmad SeyedAlinaghi, et al.
Published: (2024-07-01)

Can children of the Sputnik V vaccine recipients become symptomatic?
by: Esmaeil Mehraeen, et al.
Published: (2021-10-01)

High Seroprevalence of SARS-CoV-2 IgG and RNA among Asymptomatic Blood Donors in Makkah Region, Saudi Arabia
by: Kamal H. Alzabeedi, et al.
Published: (2022-08-01)

Factors Affecting SARS-CoV-2 IgG Production after Vaccination and/or Disease: A Large-Scale Seroprevalence Study
by: Tanja Karl, et al.
Published: (2023-10-01)

Seroprevalence of diphtheria IgG antibodies among 5–20 years old in diphtheria affected regions during 2018–19: Evidence in support of the revised National Vaccine Policy for diphtheria in India
by: Bindu R. Madhavi, et al.
Published: (2024-01-01)

Survival factors affecting the infectivity of hepatitis A virus isolated from Egypt
by: Abdallah Ragab, et al.
Published: (2024-02-01)

Age-specific Prevalence of Antibodies to Hepatitis A in Children and Adolescents from Rio de Janeiro, Brazil, 1978 and 1995: Relationship of Prevalence to Environmental Factors
by: Claudia L Vitral, et al.
Published: (1998-01-01)

Assessing the Pre-Vaccination Anti-SARS-CoV-2 IgG Seroprevalence among Residents and Staff in Nursing Home in Niigata, Japan, November 2020
by: Keita Wagatsuma, et al.
Published: (2022-11-01)